Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.
11 results about "Xylose Reductase" patented technology
Filter
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Xylose metabolism. D-Xylose is a five-carbon aldose (pentose, monosaccharide) that can be catabolized or metabolized into useful products by a variety of organisms. There are at least four different pathways for the catabolism of D-xylose: An oxido-reductase pathway is present in eukaryotic microorganisms.
The invention provides a strain for producing beta-carotene as well as a construction method and application of the strain, and belongs to the technical field of synthetic biology and genetic engineering. The construction method of the MYy107 strain disclosed by the invention comprises the following steps: step 1, integrating a mevalonate kinasegeneERG12, a phosphomevalonate kinasegeneERG8, a mevalonate diphosphate decarboxylase geneERG19 and an isopentene diphosphate isomerase gene IDI1 on an RT08 bacterium, so as to obtain an RT10 strain; 2, a xylosereductase gene XYL1, a xylitoldehydrogenase gene XYL2, a xyloseisomerasemutant XylA3 * and a xylulokinase gene Yl.Xk are integrated on the RT10 strain, and the MYy107 strain is obtained. According to the MYy107 strain constructed by the invention, the beta-carotene can be produced by using xylose and acetic acid at the same time, and the yield of the beta-carotene is remarkably improved and reaches 710.01 mg / L.
The application discloses a genetically engineeredbacillus subtilis for producing porphyra-334, a kind of bacteriosporin amino acid, and a construction method and application thereof, and belongs to the field of microbial metabolic engineering and synthetic biology.The strain takes bacillus subtilis WB600 as a starting bacterium: 1) a competitive pathway gene ywjH is knocked out to strengthen precursor supply;2) a gene cluster NlmysABCD derived from a porphea lincolnii is integrated in multiple copies to enhance pathway flux;3) sporulation genes spo0A and spoIIIE and threonine degradation gene tdh are knocked out to block byproduct generation and redistribute metabolic resources;4) xylosemetabolism genes xylAB are introduced.The yield of porphyra-334 of the engineered bacterium reaches 3.38 g / L in shake flaskfermentation, and the yield is increased to 15.1 g / L in 50 L fermenter fed-batch culture.
This invention discloses a genetically engineeredBacillus subtilis strain for producing Mycosporine-glycine, its construction method, and its applications. Starting with Bacillus subtilis WB600, this strain significantly enhances Mycosporine-glycine synthesis by knocking out the competing pathway gene ywjH and expressing the AvmysABC gene cluster from Anabaena polymorpha at multiple sites. Further knocking out the sporulation genes spo0A and spoIIIE and introducing the xylosemetabolismgene clusters xylA-xylB, combined with a mixed carbon sourcefermentation strategy, significantly increased the yield. The engineered strain achieved a Mycosporine-glycine yield of 3.64 g / L in shake-flask fermentation and 15.8 g / L in a 50 L fed-batch fermenter.
The invention belongs to the technical field of microbial geneticengineering and industrial fermentation, and discloses an aspergillus niger engineering strain for producing L-malic acid by using xylose and a construction method and application of the aspergillus niger engineering strain. A three-gene recombination strain of an XR gene for coding xylosereductase, an XDH gene for coding xylitoldehydrogenase and an XK gene for coding xylulokinase through simultaneous overexpression is obtained through directional construction. Through synergistic overexpression of the XR gene, the XDH gene and the XK gene, the limitation that the starting strain LH-1 cannot utilize the xylose is successfully broken through, and effective utilization and directional conversion of the xylose are realized. The strain can be used for producing L-malic acid by using a low-cost xylose raw material, so that the production cost is remarkably reduced, a new technical path is provided for industrial production of organic acid, and the strain has a wide industrial application prospect.